Phathom Pharmaceuticals, Inc. (PHAT) Covered Calls

You can sell covered calls on Phathom Pharmaceuticals, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PHAT (prices last updated Fri 4:16 PM ET):

Phathom Pharmaceuticals, Inc. (PHAT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
8.78 -0.31 8.52 8.78 2.1M - 0.6
Covered Calls For Phathom Pharmaceuticals, Inc. (PHAT)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 20 10 0.65 8.13 8.0% 81.1%
Jan 17 10 0.70 8.08 8.7% 49.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is based in Buffalo Grove, Illinois.